Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges

BMC Medical Genomics

Doris M Jacobs³  Ben van Ommen¹  John van Duynhoven²  Ruud Albers²  Henk FJ Hendriks¹  Paul van der Logt⁴  Leon Frenken⁴  Nicole Cnubben¹  Ursula Garczarek⁴  Esther Boelsma¹  Ferdi A van Dorsten³  Bas Kremer¹  Michiel Gribnau⁴  Marjan van Erk¹  Danielle Wolvers⁴  Suzan Wopereis¹ 

[1] TNO, Utrechtseweg 48, Zeist 3704 HE, The Netherlands;Wageningen University, Dreijenlaan 3, Wageningen 6703 HA, The Netherlands;Netherlands Metabolomics Centre, Einsteinweg 55, 2333 CL, Leiden, The Netherlands;Unilever R&D, Olivier van Noortlaan 120, Vlaardingen 3130 AC, The Netherlands

关键词: Glucose;    Lipid;    Oxylipins;    Resilience;    Inflammation;    Challenge test;    OLTT;    OGTT;   

Others  :  1091667
DOI  :  10.1186/1755-8794-6-44

 received in 2012-12-13, accepted in 2013-10-18,  发布年份 2013

【 摘 要 】

Background

Resilience or the ability of our body to cope with daily-life challenges has been proposed as a new definition of health, with restoration of homeostasis as target resultant of various physiological stress responses. Challenge models may thus be a sensitive measure to study the body’s health. The objective of this study was to select a dietary challenge model for the assessment of inflammatory resilience. Meals are a challenge to metabolic homeostasis and are suggested to affect inflammatory pathways, yet data in literature are limited and inconsistent.

Method

The kinetic responses of three different dietary challenges and a water control challenge were assessed on various metabolic and inflammatory markers in 14 healthy males and females using a full cross-over study design. The dietary challenges included glucose (75 g glucose in 300 ml water), lipids (200 ml whipping cream) and a mix of glucose and lipids (same amounts as above), respectively. Blood samples were collected at baseline and at 0.5, 1, 2, 4, 6, 8 and 10 h after consumption of the treatment products. Inflammation (IFNγ, IL-1β, IL-6, IL-8, IL-10, IL-12p70, TNF-α CRP, ICAM-1, VCAM-1, SAA, E-selectin, P-selectin, thrombomodulin, leukocytes, neutrophils, lymphocytes) and clinical (e.g. glucose, insulin, triglycerides) markers as well as gene expression in blood cells and plasma oxylipin profiles were measured.

Results

All three dietary challenges induced changes related to metabolic control such as increases in glucose and insulin after the glucose challenge and increases in triglycerides after the lipid challenge. In addition, differences between the challenges were observed for precursor oxylipins and some downstream metabolites including DiHETrE’s and HODE’s. However, none of the dietary challenges induced an acute inflammatory response, except for a modest increase in circulating leukocyte numbers after the glucose and mix challenges. Furthermore, subtle, yet statistically significant increases in vascular inflammatory markers (sICAM-1 and sVCAM-1) were found after the mix challenge, when compared to the water control challenge.

Conclusions

This study shows that dietary glucose and lipid challenges did not induce a strong acute inflammatory response in healthy subjects, as quantified by an accurate and broad panel of parameters.

【 授权许可】

   
2013 Wopereis et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]WHO: Constitution of the world health organization. 2006. http://www.who.int/governance/eb/who_constitution_en.pdf webcite
• [2]Huber M, Knottnerus JA, Green L, der HH v, Jadad AR, Kromhout D, et al.: How should we define health? BMJ 2011, 343:d4163.
• [3]Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, et al.: The dynamic range of the human metabolome revealed by challenges. FASEB J 2012, 26:2607-2619.
• [4]van OB, Keijer J, Heil SG, Kaput J: Challenging homeostasis to define biomarkers for nutrition related health. Mol Nutr Food Res 2009, 53:795-804.
• [5]Hotamisligil GS, Erbay E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008, 8:923-934.
• [6]Margioris AN: Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:129-137.
• [7]Blackburn P, Despres JP, Lamarche B, Tremblay A, Bergeron J, Lemieux I, et al.: Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 2006, 14:1747-1754.
• [8]Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da RR, Maier A, et al.: Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004, 53:701-710.
• [9]Ceriello A, Assaloni R, Da RR, Maier A, Piconi L, Quagliaro L, et al.: Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005, 111:2518-2524.
• [10]Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P, et al.: Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010, 33:991-997.
• [11]Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
• [12]van Oostrom AJ, Sijmonsma TP, Rabelink TJ, Van Asbeck BS, Cabezas MC: Postprandial leukocyte increase in healthy subjects. Metabolism 2003, 52:199-202.
• [13]van Oostrom AJ, van Wijk JP, Sijmonsma TP, Rabelink TJ, Castro Cabezas M: Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med 2004, 62:320-325.
• [14]van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, et al.: Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004, 177:175-182.
• [15]Derosa G, Ferrari I, D’Angelo A, Salvadeo SA, Fogari E, Gravina A, et al.: Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 2009, 24:204-210.
• [16]Derosa G, D’Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, et al.: Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects. Microvasc Res 2010, 79:144-149.
• [17]Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mulvey TB, Chan YK, et al.: Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Nutrition 2008, 24:322-329.
• [18]Tulk HM, Robinson LE: Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism 2009, 58:1709-1716.
• [19]Julious SA: Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005, 4:287-291.
• [20]Chilton NW: The latin square design in clinical experimentation. J Dent Res 1955, 34:421-428.
• [21]Balvers MGJ, Verhoeckx KCM, Bijlsma S, Rubingh CM, Meijerink J, Wortelboer HM, et al.: Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics 2012, 8:1130-1147.
• [22]Lundman P, Boquist S, Samnegard A, Bennermo M, Held C, Ericsson CG, et al.: A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis 2007, 17:195-202.
• [23]Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, et al.: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002, 39:1145-1150.
• [24]Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, et al.: An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr 2010, 91:1044-1059.
• [25]van Erk MJ, Wopereis S, Rubingh C, Van VT, Verheij E, Cnubben NH, et al.: Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Med Genomics 2010, 3:5. BioMed Central Full Text
• [26]Cheng YC, Kao WH, Mitchell BD, Sharrett AR, Ryan KA, Vogel RA, et al.: Genetic effects on postprandial variations of inflammatory markers in healthy individuals. Obesity (Silver Spring) 2010, 18:1417-1422.
• [27]MacEneaney OJ, Harrison M, O’Gorman DJ, Pankratieva EV, O’Connor PL, Moyna NM: Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. Eur J Appl Physiol 2009, 106:721-729.
• [28]Tamburrelli C, Gianfagna F, D’Imperio M, De CA, Rotilio D, Iacoviello L, et al.: Postprandial cell inflammatory response to a standardised fatty meal in subjects at different degree of cardiovascular risk. Thromb Haemost 2012, 107:530-537.
• [29]van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, et al.: Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003, 44:576-583.
• [30]Derosa G, D’Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, et al.: Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients. Horm Metab Res 2010, 42:8-13.
• [31]Campbell CG, Brown BD, Dufner D, Thorland WG: Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 2006, 41:257-265.
• [32]van Dijk SJ, Mensink M, Esser D, Feskens EJ, Muller M, Afman LA: Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. PLoS One 2012, 7:e41388.
• [33]Madec S, Corretti V, Santini E, Ferrannini E, Solini A: Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. Br J Nutr 2011, 106:364-368.
• [34]Shearer GC, Newman JW: Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Curr Atheroscler Rep 2009, 11:403-410.
• [35]Giordano RM, Newman JW, Pedersen TL, Ramos MI, Stebbins CL: Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers. Int J Sport Nutr Exerc Metab 2011, 21:471-479.
• [36]Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC: Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res 2009, 50:204-213.
• [37]Buchanan MR, Horsewood P, Brister SJ: Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE. Prostaglandins Leukot Essent Fatty Acids 1998, 58:339-346.
• [38]Xi S, Pham H, Ziboh VA: Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid. Prostaglandins Leukot Essent Fatty Acids 2000, 62:13-19.
• [39]Lefebvre P, Chinetti G, Fruchart JC, Staels B: Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006, 116:571-580.
• [40]Chinetti G, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000, 49:497-505.
• [41]Shearer GC, Harris WS, Pedersen TL, Newman JW: Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 2010, 51:2074-2081.
• [42]Konkel A, Schunck WH: Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta 2011, 1814:210-222.
• [43]Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, et al.: Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. J Nutr Biochem 2009, 20:694-704.
• [44]Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 2004, 34:766-773.
• [45]Dixon NC, Hurst TL, Talbot DC, Tyrrell RM, Thompson D: Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. J Appl Physiol 2009, 107:63-68.
• [46]Gudmundsson A, Ershler WB, Goodman B, Lent SJ, Barczi S, Carnes M: Serum concentrations of interleukin-6 are increased when sampled through an indwelling venous catheter. Clin Chem 1997, 43:2199-2201.
• [47]Kempf K, Haltern G, Futh R, Herder C, Muller-Scholze S, Gulker H, et al.: Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction. Horm Metab Res 2006, 38:346-351.
• [48]Manning PJ, Sutherland WH, McGrath MM, de Jong SA, Walker RJ, Williams MJ: Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 2008, 16:2046-2052.
• [49]Metzig AM, Schwarzenberg SJ, Fox CK, Deering MM, Nathan BM, Kelly AS: Postprandial endothelial function, inflammation, and oxidative stress in obese children and adolescents. Obesity (Silver Spring) 2011, 19:1279-1283.
• [50]Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al.: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997, 82:4196-4200.
• [51]Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Fuerstenberg RK, Weatherbee JA, et al.: Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo 1995, 9:331-339.
• [52]Taudorf S, Krabbe KS, Berg RM, Pedersen BK, Moller K: Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin Vaccine Immunol 2007, 14:250-255.